跳至主要内容
临床试验/NCT00325221
NCT00325221已完成不适用

QUANTUM - Quality-of-Life, Anxiety and Depression in ICD Patients Using Home Monitoring

Biotronik SE & Co. KG14 个研究点 分布在 3 个国家目标入组 148 人开始时间: 2006年8月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
148
试验地点
14
主要终点
Hospital Anxiety and Depression Scale (HADS) anxiety score

研究概览

简要总结

Quality of life (QOL) and psychological well-being of patients with implantable cardioverter-defibrillators (ICDs) are significantly influenced by the experience of shock therapies. A close therapeutic relationship between patients and physicians, resulting in short reaction times to ICD-treated arrhythmic events and, in an optimised antiarrhythmic therapy, may help the patients to deal with their situations in the best possible way.

The researchers investigate the influence of automatic remote patient monitoring on QOL, anxiety, and depression in ICD patients, and kind and frequency of (un-)scheduled patient-physician contacts. They also evaluate monitoring-induced changes in patient mobility and in patients' perceptions of ICD therapy.

详细描述

Our study investigates the influence of automatic remote patient monitoring on quality of life (QOL), anxiety and depression in patients with implantable cardioverter-defibrillators (ICDs), and frequency of (un-)scheduled patient-physician contacts. The study also evaluates monitoring-induced changes in patient mobility and in patients' perceptions of ICD therapy.

The patients will receive BIOTRONIK Lexos-T or Lumos-T ICD models, with the integrated Home Monitoring capability. The latter allows wireless, everyday transfer of the essential status and therapy data from the ICD memory to a website accessible by the attending physicians. The website is managed by BIOTRONIK Home Monitoring Service Center.

Patients will be randomised into:

  • Group 1: Home Monitoring is established from the outset.
  • Group 2: Home Monitoring is introduced 9 months after ICD implantation.

Follow-up for both groups is 18 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Indication for ICD implantation either as primary or secondary prevention
  • Patient informed consent

排除标准

  • ICD replacement indication
  • Indication for cardiac resynchronisation therapy
  • Inability to fully understand psychosomatic questionnaires, especially cognitive impairment or German language deficits
  • Co-morbidities with a resulting life expectancy of less than one year
  • Psychosomatic disease (requiring psychiatric therapy)
  • Age <18 years
  • Patients who are already enrolled in another study

研究组 & 干预措施

Home Monitoring Off

Experimental

Home Monitoring activated 9 months after implantation (Intervention HM Off)

干预措施: HM Off (Device)

Home Monitoring On

Experimental

Home Monitoring activated after implantation (Intervention HM On)

干预措施: HM on (Device)

结局指标

主要结局

Hospital Anxiety and Depression Scale (HADS) anxiety score

时间窗: 9 and 18 months

次要结局

  • Quality of life (SF-12)(9 and 18 months)
  • Patient's perception of ICD therapy(9 and 18 months)
  • Prevalence of Type D personality among ICD patients(9 and 18 months)
  • HADS depression score(9 and 18 months)
  • Frequency of contacts between patient and physician(9 and 18 months)
  • Patient mobility(9 and 18 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (14)

Loading locations...

相似试验